Abstract
We herein report an asymmetric protocol to access a series of orthogonally functionalized acyclic chiral target molecules containing a quaternary stereogenic center by carrying out the enantioselective α‐alkylation of novel orthogonally functionalized dioxolane‐containing cyanoacetates under chiral ammonium salt catalysis. By using just 1 mol % of Maruoka's spirocyclic ammonium salt catalysts enantioselectivities up to e.r.=97.5 : 2.5 could be achieved and further functional group manipulations of the products were carried out as well.
Keywords: ammonium salt catalysis, asymmetric alkylation reactions, cyanoacetates, phase-transfer catalysis, quaternary stereogenic centers
Highly functionalized acyclic compounds bearing a quaternary stereocenter can be accessed by using a chiral ammonium salt‐catalyzed α‐alkylation protocol.
1. Introduction
The enantioselective construction of quaternary stereogenic centers, or so called all‐carbon stereocenters, has for decades been a topic of uttermost importance [1] and the development of novel, especially asymmetric catalysis‐based, strategies is a worthwhile task.[ 1 , 2 , 3 ] Enantioselective catalytic α‐alkylation reactions of suited prochiral C‐pronucleophiles, [4] i. e. enolate analogues, are amongst the most versatile approaches to install stereogenic centers and the use of appropriately α‐trisubstituted carbonyl‐ or carboxylic acid‐analogues allows for the direct formation of quaternary stereogenic centers.[ 3 , 4 ] Asymmetric ion‐pairing organocatalysis, i. e. chiral ammonium salt catalysis, has emerged as one of the outstanding non‐covalent catalysis principles over the last four decades. [5] Very remarkably, this concept has proven its potential for stereoselective enolate α‐functionalizations ever since the pioneering contributions by Merck scientists, who first reported the chiral ammonium salt catalyzed α‐alkylation of phenylindanone derivatives in 1984 already, [6] and O'Donnell's group who introduced glycine Schiff base α‐alkylations in 1989. [7] Following these seminal contributions, the use of chiral ammonium salts became a well‐described methodology for asymmetric α‐alkylations and over the years also various approaches for the construction of quaternary stereocenters by reacting cyclic[ 6 , 8 ] as well as acyclic [9] prochiral enolate analogues with Csp3‐alkylating agents (i. e. alkylhalides) have been introduced. Our groups have been engaged in the design and use of chiral ammonium salt catalysts for (novel) asymmetric α‐(hetero)functionalizations of prochiral C‐nucleophiles for a while.[ 10 , 11 ] Based on the general high interest in acyclic compounds bearing a quaternary stereogenic center we now became interested in introducing the novel orthogonally functionalized α‐cyanoacetates 3 as a versatile substrate for (chiral ammonium salt‐catalyzed) asymmetric α‐alkylations. [12] As outlined in Scheme 1, these starting materials should be accessible by alkylation of cyanoacetates 1 with the dioxolane‐based electrophile 2 and asymmetric α‐alkylations with Csp3‐based electrophiles 4 will give access to the highly functionalized chiral acyclic targets 5 then.
Scheme 1.
Investigated use of compounds 3 to access acyclic targets 5 under asymmetric ammonium salt catalysis.
2. Results and Discussion
We started our investigations by focusing on the α‐benzylation of the t‐butyl ester 3 a, which was accessed by alkylation of the corresponding cyanoacetate 1 a with 2, [13] in the presence of the established chiral ammonium salts A,[ 5 , 6 , 7 , 14 ] B,[ 10b , 10c ] and C[ 5 , 15 ] (Table 1 gives an overview about the most significant results obtained in a detailed screening of different conditions). First experiments with Cinchona alkaloid‐based ammonium salts A1 and A2 under classical biphasic phase‐transfer conditions (toluene / aqueous KOH) allowed for very clean reactions and gave product 5 a in excellent yields after 2 h, but in a more or less racemic manner only (entries 1 and 2). Other Cinchona alkaloid‐based ammonium salts were tested under various conditions too, but no improvement was possible (details not given in the table). We next tested our own bifunctional ammonium salts B, but unfortunately these systems were not selective at all either (for a representative example see entry 3). Gratifyingly however, when using Maruoka's structurally more rigid spiro ammonium salt C1 next, literally the first experiment with 5 mol % of this catalyst gave product 5 a in a high isolated yield (87 %) and with good enantioselectivity (e.r.=94 : 6). Remarkably, when lowering the catalyst loading to 1 mol % only, the e.r. could even be improved to 96.5 : 3.5 (entry 5). Interestingly, catalyst C2 performed notably less selective (entry 6) and we therefore screened a variety of different conditions with C1 next (entries 7–13). Surprisingly however, neither the use of other solvents (entries 7 and 8), nor the use of other aqueous or solid bases (entries 9–11) did allow for any improvement. When lowering the temperature, the e.r. could not be improved further, but instead the reaction only slowed down significantly.
Table 1.
Identification of the best‐suited conditions for the asymmetric synthesis of 5 a.[a]
|
| |||||||
|---|---|---|---|---|---|---|---|
|
Entry |
Cat. |
Solv. |
Base |
T [°C] |
t [h] |
Yield [%][b] |
e.r.[c] |
|
1 |
A1 (5 %) |
toluene |
KOH(50 %) (30 eq.) |
0 |
2 |
86 |
56 : 44 |
|
2 |
A2 (5 %) |
toluene |
KOH(50 %) (30 eq.) |
0 |
2 |
88 |
51 : 49 |
|
3 |
B1 (5 %) |
toluene |
KOH(50 %) (30 eq.) |
0 |
2 |
75 |
47 : 53 |
|
4 |
C1 (5 %) |
toluene |
KOH(50 %) (30 eq.) |
0 |
2 |
87 |
94 : 6 |
|
5 |
C1 (1 %) |
toluene |
KOH(50 %) (30 eq.) |
0 |
2 |
86 |
96.5 : 3.5 |
|
6 |
C2 (1 %) |
toluene |
KOH(50 %) (30 eq.) |
0 |
2 |
89 |
84 : 16 |
|
7 |
C1 (1 %) |
CH2Cl2 |
KOH(50 %) (30 eq.) |
0 |
2 |
89 |
66 : 34 |
|
8 |
C1 (1 %) |
MTBE |
KOH(50 %) (30 eq.) |
0 |
2 |
88 |
89 : 11 |
|
9 |
C1 (1 %) |
toluene |
KOH(s) (6 eq.) |
0 |
2 |
85 |
95 : 5 |
|
10 |
C1 (1 %) |
toluene |
Cs2CO3(s) (6 eq.) |
0 |
20[d] |
87 |
88 : 12 |
|
11 |
C1 (1 %) |
toluene |
NaOH(50 %) (30 eq.) |
0 |
2 |
87 |
93 : 7 |
|
12 |
C1 (1 %) |
toluene |
KOH(50 %) (30 eq.) |
−20 |
20[d] |
93 |
96 : 4 |
|
13 |
C1 (1 %) |
toluene |
KOH(50 %) (30 eq.) |
−78 |
20[d] |
70 |
96 : 4 |
[a] Unless otherwise stated all reactions were carried out using 0.1 mmol 3 a and 0.12 mmol 4 a in the indicated solvent (0.09 M with respect to 3 a); [b] Isolated yields. [c] Determined by HPLC using a chiral stationary phase. Given as the ratio of (−)‐5 a : (+)‐5 a. [d] Incomplete conversion after 2 h.
Accordingly, the initially identified conditions (entry 5) remained the best‐suited, giving product 5 a in excellent yield and very good enantioselectivity under operationally simple conditions.
With this optimized procedure at hand, we next investigated the application scope of this methodology by testing the synthesis of a variety of novel acyclic targets 5 containing a quaternary stereogenic center as outlined in Scheme 2 (all reactions were run for 20 h to ensure complete conversion of starting material 3 in each case). Varying the ester group R1 of starting material 3 revealed that less bulky esters perform clearly less selective compared to the initially used t‐butyl ester (compare products 5 a–c). Carrying out the alkylation of 3 a with different electrophiles showed that different benzylic halides allow for more or less similar selectivities and high yields (products 5 g–q), while allylbromide (product 5 d), methyliodide (product 5 e) and 2,2‐difluoroethyl triflate (product 5 f) gave lower selectivities only. Nevertheless, the application scope was in general relatively broad and robust and we also found that the use of the (S,S)‐catalyst enantiomer always gives (+)‐5 derivatives, while (R,R)‐C1 results in the formation of the (−)‐enantiomers exclusively.
Scheme 2.
Applications scope of the asymmetric α‐alkylation of dioxolane‐containing cyanoacetates 3.
Finally, we also tested the suitability of product 5 a to undergo further functional group manipulations (Scheme 3; all these reactions were carried out on racemic material without any extensive optimization of conditions and yield and should serve as a proof‐of‐concept mainly). It was possible to either selectivity hydrolyze the nitrile group under basic oxidative conditions (giving the primary amide‐containing 6) or debutylate the ester under acidic conditions (accessing the free acid 7). Surprisingly however, attempts to selectively hydrolyze the acetal failed, resulting in several unidentified decomposition products only. Furthermore, reduction with a stoichiometric amount of LiAlH4 resulted in the formation of a separable mixture of the alcohol 9 and the decarboxylated product 10, while the use of an excess of LiAlH4 allowed for the reduction of both, the nitrile and the ester group (giving the diacetate 8 after protection with Ac2O), demonstrating the versatility of products 5 for further transformations.
Scheme 3.
Functional group manipulations of product 5 a [a) H2O2, Na2CO3; b) TFA; c) LiAlH4 (1.2 eq.); d) LiAlH4 (10 eq.) followed by Ac2O, pyridine]. [13]
3. Conclusions
Summing our investigations up, we identified robust and functional group‐tolerant conditions to carry out the asymmetric α‐alkylation of the novel orthogonally functionalized dioxolane‐containing cyanoacetates 3 under chiral ammonium salt catalysis. Key to success was the use of the structurally rigid spirocyclic Maruoka ammonium salt catalysts C, which gave access to the acyclic products 5, which contain a quaternary stereogenic center, with enantioselectivities up to e.r.=97.5 : 2.5 when using just 1 mol % of the catalyst.
Experimental Section
General details can be found in the online supporting information. This document contains the analytical data of the reaction products as well as copies of NMR spectra and HPLC traces.
General asymmetric α‐alkylation procedure: A solution of starting material 3 (0.10 mmol) in 1.2 mL toluene is cooled to 0 °C (Ar‐atmosphere). Subsequently, catalyst C1 (1 mol‐%, 1.1 mg), aq. KOH50% (227 μL, 30 eq) and electrophile 4 (0.12 mmol, 1.2 eq.) are added and the reaction mixture is stirred for 20 h (slow warm up to RT). Then 3.0 mL diethyl ether and 1.5 mL water are added and the phases are separated. The aqueous layer is extracted 5× with 2 mL Et2O each and the combined org. phases are washed with 7 mL brine. The org. phase is dried over Na2SO4, filtered over cotton and the solvent is evaporated. Purification of the crude products are performed by column chromatography using heptane:EtOAc 20/1 to 10/1.
Product 5 a. Prepared according to the general procedure and isolated as an almost colorless oil in 86 % yield and with e.r.=96.5 : 3.5. 1H‐NMR (300 MHz, CDCl3, 298.0 K, δ [ppm]): 7.28–7.37 (m, 5H), 5.19 (dd, J1 =6.3 Hz, J2 =3.2 Hz, 1H), 3.81–4.04 (m, 4H), 3.17 (d, J=13.5 Hz, 1H), 3.07 (d, J=13.5 Hz, 1H), 2.38 (dd, J1 =14.1 Hz, J2 =6.3 Hz, 1H), 2.13 (dd, J1 =14.1 Hz, J2 =3.2 Hz, 1H), 1.35 (s, 9H). 13 C‐NMR (75 MHz, CDCl3, 298.0 K, δ [ppm]): 167.1 (1C), 133.9 (1C), 130.5 (2C), 128.5 (2C), 127.9 (1C), 118.8 (1C), 101.4 (1C), 84.0 (1C), 65.3 (1C), 64.8 (1C), 47.7 (1C), 43.9 (1C), 40.4 (1C), 27.7 (3C). HRMS of C18H23NO4: m/z calculated for [M+NH4]+: 335.1965; found: 335.1974. [α]D 24 (c=1.00, CHCl3)=−24.5. HPLC (Chiralpak AD‐H, hexane/i‐PrOH 10/1, 0.5 mL min−1, 10 °C) retention times: t major=19.0 min, t minor=26.9 min.
Conflict of interest
The authors declare no conflict of interest.
Supporting information
As a service to our authors and readers, this journal provides supporting information supplied by the authors. Such materials are peer reviewed and may be re‐organized for online delivery, but are not copy‐edited or typeset. Technical support issues arising from supporting information (other than missing files) should be addressed to the authors.
Supporting Information
Acknowledgements
This work was generously supported by the Austrian Science Funds (FWF) Project No. P30237. The NMR spectrometers used at JKU Linz were acquired in collaboration with the University of South Bohemia (CZ) with financial support from the European Union through the EFRE INTERREG IV ETC‐AT‐CZ program (project M00146, “RERI‐uasb”). We are grateful to DI Thomas Bögl, JKU Linz, for support with HRMS measurements.
K. Röser, B. Berger, M. Widhalm, M. Waser, ChemistryOpen 2021, 10, 756.
Contributor Information
Prof. Michael Widhalm, Email: m.widhalm@univie.ac.at.
Prof. Mario Waser, Email: mario.waser@jku.at.
References
- 1. Christoffers J., Baro A., Quaternary Stereocenters: Challenges and Solutions for Organic Synthesis, 2005, WILEY-VCH, Weinheim. [Google Scholar]
- 2.For illustrative overviews:
- 2a. Douglas C. J., Overman L. E., Proc. Natl. Acad. Sci. USA 2004, 101, 5363–5367; [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2b. Das J. P., Marek I., Chem. Commun. 2011, 47, 4593–4623; [DOI] [PubMed] [Google Scholar]
- 2c. Quasdorf K. W., Overman L. E., Nature 2014, 516, 181–191; [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2d. Liu Y., Han S.-J., Liu W. B., Stoltz B. M., Acc. Chem. Res. 2015, 48, 740–751; [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2e. Marek I., Minko Y., Pasco M., Mejuch T., Gilboa N., Chechik H., Das J. P., J. Am. Chem. Soc. 2014, 136, 2682–2694; [DOI] [PubMed] [Google Scholar]
- 2f. Zeng X.-P., Cao Z.-Y., Wang Y.-H., Zhou F., Zhou J., Chem. Rev. 2016, 116, 7330–7396; [DOI] [PubMed] [Google Scholar]
- 2g. Li C., Ragab S. S., Liu G., Tang W., Nat. Prod. Rep. 2020, 37, 276–292. [DOI] [PubMed] [Google Scholar]
- 3.
- 3a. Trost B. M., Schultz J. E., Synthesis 2019, 51, 1–30; [Google Scholar]
- 3b. Süsse L., Stoltz B. M., Chem. Rev. 2021, 121, 4084–4099. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.For selected overviews:
- 4a. Tak-Tak L., Dhimane H., Dalko P. I., Angew. Chem. Int. Ed. 2011, 50, 12146–12147; [DOI] [PubMed] [Google Scholar]; Angew. Chem. 2011, 123, 12350–12352; [Google Scholar]
- 4b. Remesm M., Vesely J., Torres R. R., Stereoselective Organocatalysis 2013, John Wiley & Sons, pp. 267–312; [Google Scholar]
- 4c. Kohler M. C., Wengryniuk S. E., Coltart D. M., Andrushko V., Andrushko N., Stereoselective Synthesis of Drugs and Natural Products, 2013, John Wiley & Sons, pp. 183–213; [Google Scholar]
- 4d. Cano R., Zakarian A., McGlacken G. P., Angew. Chem. Int. Ed. 2017, 56, 9278–9290; [DOI] [PMC free article] [PubMed] [Google Scholar]; Angew. Chem. 2017, 129, 9406–9418. [Google Scholar]
- 5.For general overviews about asymmetric ion pairing catalysis:
- 5a. O'Donnell M. J., Ojima I., Catalytic Asymmetric Syntheses, 2 nd ed., 2000, Wiley-VCH, New York, pp. 727–755; [Google Scholar]
- 5b. Maruoka K., Asymmetric Phase Transfer Catalysis 2008, Wiley-VCH, Weinheim; [Google Scholar]
- 5c. O'Donnell M. J., Acc. Chem. Res. 2004, 37, 506–517; [DOI] [PubMed] [Google Scholar]
- 5d. Lygo B., Andrews B. I., Acc. Chem. Res. 2004, 37, 518–525; [DOI] [PubMed] [Google Scholar]
- 5e. Hashimoto T., Maruoka K., Chem. Rev. 2007, 107, 5656–5682; [DOI] [PubMed] [Google Scholar]
- 5f. Ooi T., Maruoka K., Angew. Chem. Int. Ed. 2007, 46, 4222–4266; [DOI] [PubMed] [Google Scholar]; Angew. Chem. 2007, 119, 4300–4345; [Google Scholar]
- 5g. Shirakawa S., Maruoka K., Angew. Chem. Int. Ed. 2013, 52, 4312–4348; [DOI] [PubMed] [Google Scholar]; Angew. Chem. 2013, 125, 4408–4445; [Google Scholar]
- 5h. Brak K., Jacobsen E. N., Angew. Chem. Int. Ed. 2013, 52, 534–561; [DOI] [PMC free article] [PubMed] [Google Scholar]; Angew. Chem. 2013, 125, 558–588; [Google Scholar]
- 5i. Tan J., Yasuda N., Org. Process Res. Dev. 2015, 19, 1731–1746; [Google Scholar]
- 5j. Kaneko S., Kumatabara Y., Shirakawa S., Org. Biomol. Chem. 2016, 14, 5367–5376; [DOI] [PubMed] [Google Scholar]
- 5k. Schörgenhumer J., Tiffner M., Waser M., Beilstein J. Org. Chem. 2017, 13, 1753–1769; [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5l. Qia D., Sun J., Chem. Eur. J. 2019, 25, 3740–3751.30358913 [Google Scholar]
- 6. Dolling U. H., Davis P., Grabowski E. J. J., J. Am. Chem. Soc. 1984, 106, 446–447. [Google Scholar]
- 7. O'Donnell M. J., Bennett W. D., Wu S., J. Am. Chem. Soc. 1989, 111, 2353–2355. [Google Scholar]
- 8.For pioneering examples describing the use of cyclic pronucleophiles:
- 8a. Dehmlow E. V., Düttmann S., Neumann B., Stammler H.-G., Eur. J. Org. Chem. 2002, 2087–2093; [Google Scholar]
- 8b. Ooi T., Miki T., Taniguchi M., Shiraishi M., Takeuchi M., Maruoka K., Angew. Chem. Int. Ed. 2003, 42, 3796–3798; [DOI] [PubMed] [Google Scholar]; Angew. Chem. 2003, 115, 3926–3928; [Google Scholar]
- 8c. Park E. J., Kim M. H., Kim D. Y., J. Org. Chem. 2004, 69, 6897–6899; [DOI] [PubMed] [Google Scholar]
- 8d. Ooi T., Miki T., Fukumoto K., Maruoka K., Adv. Synth. Catal. 2006, 348, 1539–1542. [Google Scholar]
- 9.For seminal contributions using acyclic pronucleophiles:
- 9a. Nagata K., Sano D., Itoh T., Synlett 2007, 547–550; [Google Scholar]
- 9b. Nagata K., Sano D., Shimizu Y., Miyazaki M., Kanemitsu T., Itoh T., Tetrahedron: Asymmetry 2009, 20, 2530–2536; [Google Scholar]
- 9c. Hong S., Lee J., Kim M., Park Y., Park C., Kim M.-h., Jew S.-s., Park H.-g., J. Am. Chem. Soc. 2011, 133, 4924–4929; [DOI] [PubMed] [Google Scholar]
- 9d. Kanemitsu T., Koga S., Nagano D., Miyazaki M., Nagata K., Itoh T., ACS Catal. 2011, 1, 1331–1335. [Google Scholar]
- 10.Examples for catalyst design:
- 10a. Waser M., Gratzer K., Herchl R., Müller N., Org. Biomol. Chem. 2012, 10, 251–254; [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10b. Novacek J., Waser M., Eur. J. Org. Chem. 2014, 802–809; [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10c. Tiffner M., Novacek J., Busillo A., Gratzer K., Massa A., Waser M, RSC Adv. 2015, 5, 78941–78949; [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10d. Tharamak S., Knittl-Frank C., Manaprasertsak A., Pengsook A., Suchy L., Schuller P., Happl B., Roller A., Widhalm M., Molecules 2018, 23, 750–767. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Recent C−C-bond forming approaches:
- 11a. Eitzinger A., Winter M., Schörgenhumer J., Waser M., Chem. Commun. 2020, 56, 579–582; [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11b. Haider V., Kreuzer V., Tiffner M., Spingler B., Waser M., Eur. J. Org. Chem. 2020, 5173–5177. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.For an overview on organocatalytic α-functionalizations of cyanoacetates: Diaz-de-Villegas M. D., Galvez J. A., Badorrey R., Lopez-Ram-de-Viu P., Adv. Synth. Catal. 2014, 356, 3261–3288. [Google Scholar]
- 13.Details can be found in the online supporting information.
- 14.For the seminal report describing the use of chiral Cinchona alkaloid-based ammonium salts: Helder R., Hummelen J. C., Laane R. W. P. M., Wiering J. S., Wynberg H., Tetrahedron Lett. 1976, 17, 1831–1834. [Google Scholar]
- 15.Pioneering report: Ooi T., Kameda M., Maruoka K., J. Am. Chem. Soc. 1999, 121, 6519–6520. [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
As a service to our authors and readers, this journal provides supporting information supplied by the authors. Such materials are peer reviewed and may be re‐organized for online delivery, but are not copy‐edited or typeset. Technical support issues arising from supporting information (other than missing files) should be addressed to the authors.
Supporting Information




